|
Volumn 177, Issue 1, 2002, Pages 49-56
|
Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane
|
Author keywords
( ) Epigallocatechin gallate; Apoptosis; Colon; Rat; Sulindac
|
Indexed keywords
AZOXYMETHANE;
EPIGALLOCATECHIN GALLATE;
SULINDAC;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARGYROPHILIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER PREVENTION;
CELL PROLIFERATION;
COLON CARCINOGENESIS;
CONTROLLED STUDY;
CRYPT CELL;
DRUG ANTAGONISM;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
AZOXYMETHANE;
CARCINOGENS;
CATECHIN;
CHORISTOMA;
COLON;
COLONIC NEOPLASMS;
DRUG SYNERGISM;
IN SITU NICK-END LABELING;
INCIDENCE;
MALE;
NUCLEOLUS ORGANIZER REGION;
PRECANCEROUS CONDITIONS;
RATS;
RATS, INBRED F344;
SULINDAC;
TEA;
|
EID: 0037040434
PISSN: 03043835
EISSN: None
Source Type: Journal
DOI: 10.1016/S0304-3835(01)00767-4 Document Type: Article |
Times cited : (91)
|
References (37)
|